摘要
Introduction Stroke is an important disease that is prevalent worldwide[1–3]. Ischemic stroke accounts for 80%of stroke cases.Currently, evidence-based effective treatments for ischemic stroke are limited, and only intravenous thrombolysis with Alteplase (a commercially available throm-
基金
supported by the Natural Science Foundation of Guangdong Province, China (2017A030313869)
the Science and Technology Project of Guangzhou City, China (201607010325)